论文部分内容阅读
《临床荟萃》1990年1期刊登的《甲硝唑治疗高脂血症的疗效观察》一文,笔者在近四个月的医疗实践中进行了验证,结果表明甲硝唑治疗内科疾病中高脂血症效果满意。 1990年2～6月笔者试用甲硝唑在住院病人中随机选择高脂血症病人:肾病综合征9例,糖尿病5例,冠心病6例,治疗方法:灭滴灵0.2,一日三次,10天为一疗程,治疗前后不用其它任何一种降脂药物。效果判定:三种疾病用一疗程后复查三项指标(甘油三脂、胆固醇,β脂蛋白)都有不同程度的降低。肾病综合征:甘油三脂、胆固醇、β脂蛋白分别下降46、28和55％;糖尿病:甘油三脂、胆固醇、β脂蛋白分别下降
“Clinical Metabolism” published in 1990 1 “metronidazole in the treatment of hyperlipidemia,” a paper, the author in the nearly four-month medical practice was verified, the results show that metronidazole in the treatment of hyperlipidemia in medical diseases Satisfactory results. From 1990 to June 1990, the author tried metronidazole in hospitalized patients randomly selected hyperlipemia patients: nephrotic syndrome in 9 cases, 5 cases of diabetes, coronary heart disease in 6 cases, treatment: metronidazole 0.2, three times a day, 10 days for a course of treatment, before and after treatment without any other lipid-lowering drugs. To determine the effect: three diseases with a review of three indicators after treatment (triglycerides, cholesterol, beta lipoprotein) have varying degrees of reduction. Nephrotic syndrome: triglyceride, cholesterol, beta lipoprotein decreased 46,28 and 55%; diabetes: triglyceride, cholesterol, beta lipoprotein decreased